Medicaid, Department of Health and Human Services (HHS), Proposed Legislation

McDermottPlus Check-Up: June 7, 2024

McDermott+ on 6/7/2024

House Oversight Subcommittee Hearing with Fauci. The hearing aimed to gather more information on the response to the COVID-19 pandemic by Anthony Fauci, MD, former National Institute of Allergy and Infectious Diseases...more

McDermottPlus Check-Up: April 26, 2024

McDermott+ on 4/26/2024

A Quiet Healthcare Week on Capitol Hill. Congress was largely in recess this week, although the Senate returned briefly to complete consideration of a long-awaited foreign aid bill. Both chambers will return to session the...more

McDermottPlus Check-Up: April 17, 2024

McDermott+ on 4/18/2024

House Energy & Commerce Health Subcommittee Holds Hearing on Cybersecurity. During the hearing, there was bipartisan concern about UnitedHealth Group’s response to the Change Healthcare cyberattack and consensus around the...more

Holland & Knight Health Dose: March 19, 2024

Holland & Knight LLP on 3/25/2024

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

Holland & Knight Health Dose: March 5, 2024

Holland & Knight LLP on 3/7/2024

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. ...more

McDermottPlus Check-Up: February 16, 2024

McDermott+ on 2/19/2024

House Energy and Commerce Health Subcommittee Holds Legislative Hearing on 19 Bills. Lawmakers discussed 19 pieces of legislation designed to support patients and caregivers in the key areas of autism, heart defects,...more

Healthcare Preview for the Week of: September 25, 2023

McDermott+ on 9/26/2023

Do We End the Week with a Shutdown? That is the question of the week. We’ll know the answer in five days, but right now, “yes” is a far more plausible answer than “no.” On the House side, Speaker McCarthy will first...more

Government Continues to Explore Role of 340B Contract Pharmacies

Goodwin on 9/15/2023

The 340B Drug Pricing Program (the “Program”) allows certain healthcare providers (“covered entities”) to purchase pharmaceuticals from drug manufacturers at discounted rates. Some covered entities do not have an internal...more

McDermottPlus Check-Up: June 16, 2023

McDermott+ on 6/16/2023

The House and Senate were both in session this week, with healthcare activity continuing at the committee level. The House Energy and Commerce Committee held hearings on the Pandemic and All Hazards Preparedness Act (PAHPA)...more

Proposed Legislation Would Require Greater Transparency and Disclosure from Hospitals, Reduce Reimbursement to Certain Off-Campus...

McDermott Will & Emery on 6/12/2023

Two bills are moving in the United States House of Representatives that have implications for hospitals and health systems, with material changes proposed regarding pricing transparency requirements, identification and...more

McDermottPlus Check-Up: May 26, 2023

McDermott+ on 5/30/2023

The House was in session this week, while the Senate was in recess. The House Energy & Commerce Committee continued its work on healthcare by advancing six bills that address competition, transparency and access to care. The...more

McDermottPlus Check-Up: April 28, 2023

McDermott+ on 5/2/2023

Congress was in session, and it was a busy healthcare week at the committee level, with six hearings focused specifically on health issues. On the House floor, Republicans passed the Limit, Save, Grow Act—a bill that raises...more

What’s Next in Washington? - July Edition

Foley & Lardner LLP on 7/8/2022

With just a few short weeks left until August recess, there is no shortage of items on the congressional to-do list. The latest round of Supreme Court decisions has inspired new action within Congress to pass legislation...more

2022 Congressional Outlook and Top 10 Federal Health Policy Issues to Watch

Holland & Knight LLP on 1/7/2022

As Congress reconvenes, it faces a packed agenda in a legislative year that will be shortened by the upcoming midterm elections and remains buffeted by the persistent coronavirus pandemic. The list of healthcare priorities is...more

Healthcare & Life Sciences: Drug Pricing Digest - October 2021

Latham & Watkins LLP on 10/12/2021

Drug Pricing Initiatives: The fate of the reconciliation package that contains many of President Biden’s domestic policy initiatives, including with respect to drug pricing, remains in limbo as Democrats continue to debate...more

Healthcare & Life Sciences: Drug Pricing Digest - May 2021 #2

Latham & Watkins LLP on 5/24/2021

PhRMA Suit Challenges Co-Pay/Accumulator Portion of December 2020 Medicaid Rule - On May 21, 2021, Pharmaceutical Research and Manufacturers of America (PhRMA) filed suit in the US District Court for the District of...more

Battle Lines Drawn with Release of Speaker’s Drug Pricing Plan

Akin Gump Strauss Hauer & Feld LLP on 10/1/2019

[co-authors: Sean Feely, Senior Public Policy Specialist and Julie E. Nolan, Senior Policy Advisor] • On September 19, Speaker Pelosi released a drug pricing plan that includes proposals for Medicare direct price...more

Changes Coming to North Carolina Medicaid in 2019

Nelson Mullins Riley & Scarborough LLP on 4/12/2019

Background - Even without expanding Medicaid under the Affordable Care Act, North Carolina has over 2.1 million residents who are Medicaid beneficiaries, and a half million of these have complex behavioral health needs....more

Health Care Policy Newsletter - July 2018 pt 2

Foley & Lardner LLP on 7/16/2018

Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly* Health Care Newsletter” in which we compile the latest Health Care policy news and legislation. *Please note that we...more

Health Care Policy Newsletter - July 2018

Foley & Lardner LLP on 7/2/2018

Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly* Health Care Newsletter” in which we compile the latest Health care policy news and legislation. *Please note that we...more

Health Care Policy Newsletter - June 2018 pt 2

Foley & Lardner LLP on 6/21/2018

Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly* Health Care Newsletter” in which we compile the latest Health care policy news and legislation. *Please note that we...more

Gold Dome Report - February 2018 #7

Nelson Mullins Riley & Scarborough LLP on 2/14/2018

Tax reform came to Georgia today with Governor Nathan Deal announcing the State’s response to last year’s federal tax reform. HB 918, carried by Deal’s floor leader Rep. Chuck Efstration (R-Dacula), allows Georgia taxpayers...more

Gold Dome Report - February 2018 #3

Nelson Mullins Riley & Scarborough LLP on 2/7/2018

All eyes are on the Amended FY 2018 Budget this week under the Gold Dome. By a vote of 167 to 8, the House adopted its Appropriations Committee’s recommendations for the Amended Budget, sending the funding proposition to the...more

Recent Congressional Actions Bring Drug Pricing Debate Back Into National Spotlight

Holland & Knight LLP on 12/5/2017

In late October, Sen. Bernie Sanders (I-VT) and Rep. Elijah Cummings (D-MD) introduced the Medicare Drug Price Negotiation Act of 2017 (S. 2011; H.R. 4138), which would allow the Department of Health and Human Services (HHS)...more

Trump Administration FY 2018 Budget and Healthcare Programs

Holland & Knight LLP on 5/29/2017

The Trump Administration released on May 23, 2017, its full Fiscal Year (FY) 2018 budget request, titled "A New Foundation for American Greatness." President Donald Trump's request builds off of the administration's March 16...more

Medicaid › Department of Health and Human Services (HHS) › Proposed Legislation

"My best business intelligence, in one easy email…"